Hers vs Fridays: Platform Breadth vs Weight-Loss Focus

Part of the PlexusDx Education Hub, this comparison examines two very different telehealth builds alongside the GLP-1 science and genetics beneath them. Explore the full Peptides & GLP-1 collection.

Independent editorial comparison. PlexusDx holds no commercial relationship with Hers or Fridays and earns no affiliate income from either program.

Full head-to-head: PlexusDx vs Fridays →

Hers is a broad, multi-condition telehealth platform; Fridays is a weight-focused program built around compounded GLP-1s. That contrast — generalist versus specialist — frames this comparison. We look at how each is structured, the identical pharmacology underneath, how transparent each is about price, and the genetic layer that sits beneath any prescription. As of April 2026.

A broad platform meets a weight-loss specialist

Hers and Fridays sit on opposite ends of a spectrum. Hers, part of Hims & Hers Health, is a multi-condition telehealth platform with weight loss as one offering; Fridays is a specialist built around compounded GLP-1 weight care. Both deliver prescriptions virtually, but one spreads across many categories while the other concentrates on a single one.

Hers: multi-condition telehealth

Hers runs as subscription telehealth inside a broad platform. Its weight track typically includes virtual clinical evaluation, provider-issued prescriptions, and either FDA-approved brand dispensing or compounded semaglutide and tirzepatide via licensed 503A pathways. Current details appear on Hers's official website.

Fridays: focused compounded weight care

Fridays concentrates on compounded GLP-1 weight management and is notably open about price. As of its own pricing page (joinfridays.com/pricing, verified 2026-07-20), it advertises compounded semaglutide at $249/mo and compounded tirzepatide at $359/mo month-to-month, with $0 membership, free shipping, and included coaching and dietitian support; prepaid bundles lower the per-month equivalent to roughly $150/mo semaglutide and $240/mo tirzepatide on a paid-annually plan. Confirm at Fridays's official website.

The identical pharmacology underneath

Platform breadth aside, both deliver the same compound class. GLP-1 receptor agonists and the dual agonist tirzepatide modulate appetite, satiety, and gastric emptying, with evidence from STEP (NEJM 2021), SURMOUNT (NEJM 2022), and SURMOUNT-OSA (NEJM 2024). The mechanism follows the molecule, not the brand delivering it.

Price transparency and what each includes

The sharpest practical difference here is disclosure. Fridays publishes month-to-month and prepaid figures plus what is bundled; Hers presents pricing within its own platform and tiers, which you should read directly. Fridays' rates moved materially within a single day, so whichever you consider, confirm the current number on the brand's own page before deciding.

The genetic variable no subscription reads

Here is the layer none of these telehealth workflows examine: the inherited biology that sets the stage before any GLP-1 molecule arrives. Differences in GLP1R, FTO, and MC4R outline the satiety and energy-balance biology that precedes any prescription from either a broad platform or a focused compounder. These are pathway-level markers. They do not predict how you will respond to any particular drug, but they describe the metabolic terrain a prescriber is writing into. The PlexusDx Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights across that terrain, mapping appetite regulation, satiety, and energy-balance biology so a conversation with your own clinician starts from data rather than guesswork. It is not a pharmacogenomic test and never forecasts a medication's effect.

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. Its month-to-month rates run roughly $60–$70/mo below Fridays' advertised month-to-month for both compounds, while Fridays' prepaid bundles undercut PlexusDx per month; the differentiator is upstream genetics.

Not affiliated: PlexusDx has no affiliation and no commercial relationship with Hers or the other programs discussed in this review.

Related reading on PlexusDx: GLP 1 Hormone, What Is GLP 1, GLP 1 What Is, GLP 1 Receptor Agonist.

Educational review only. PlexusDx has no affiliation with Hers or Fridays and no commercial relationship with either. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols, and this piece compares telehealth models. The Precision Peptide Genetic Test analyzes gene–pathway influence and predicts no drug outcome. Speak with a qualified healthcare provider first.

Weigh a third route: explore the PlexusDx Weight Management Protocols, or begin with the Precision Peptide Genetic Test to understand your metabolic genetics before deciding.

Frequently Asked Questions

Should I choose Hers or Fridays for GLP-1 care?

Neither is universally better. Hers offers weight care within a broad multi-condition platform; Fridays is a focused compounded specialist with published pricing. The fit depends on whether you value platform breadth or category focus, plus cost and structure. Review each brand's current details before deciding, since both can prescribe the same compounds.

Is Fridays or Hers more upfront about pricing?

Fridays publishes month-to-month and prepaid figures plus what is bundled directly on its pricing page. Hers presents pricing within its own platform and tiers, which you should read on its site. Because Fridays' rates moved materially within a single day, confirm any current number before committing to either program.

Do both offer compounded semaglutide and tirzepatide?

Both can dispense GLP-1 receptor agonists and the dual agonist tirzepatide, including compounded 503A preparations through licensed pharmacies, subject to eligibility. The compound class is identical; the dispensing pathway, tiers, and provider model differ. Confirm which formulation and pathway a specific order uses on each brand's own website.

Where does genetic testing fit in this comparison?

It operates before either prescription. The Precision Peptide Genetic Test maps pathway-level variants in FTO, and MC4R that describe your baseline metabolism. It does not predict how Hers, Fridays, or any compound will perform, but it lets you enter the decision with context rather than guesswork.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education.